Ranbaxy's New Head Says Firm's Focus To Remain On Generics
This article was originally published in PharmAsia News
Executive Summary
India's Ranbaxy Laboratories became a powerhouse in the generics sector of the drug-making industry and intends to retain that position under Japanese control